Key result
Cinnamic acid derivatives protected rat and human cardiomyocytes against doxorubicin-induced cardiotoxicity by ameliorating oxidative stress, reducing caspase levels, and preventing motility inhibition.
Why the study?
Clinical use of doxorubicin is severely limited by cumulative cardiotoxicity, and no universal and highly effective protective therapy has been introduced.
Cinnamic acid derivatives demonstrate multidirectional cardioprotective effects against doxorubicin-induced toxicity in vitro, suggesting potential as lead structures for novel cardioprotective therapeutics.
Answers are grounded in this paper and cite their sources.
Does not support clinical use; leaves open further development of cinnamic acid derivatives against doxorubicin cardiotoxicity.
Doxorubicin (DOX) is a widely used anticancer drug. However, its clinical use is severely limited due to drug-induced cumulative cardiotoxicity, which leads to progressive cardiomyocyte dysfunction and heart failure. Enormous efforts have been made to identify potential strategies to alleviate DOX-induced cardiotoxicity; however, to date, no universal and highly effective therapy has been introduced. Here we reported that cinnamic acid (CA) derivatives exert a multitarget protective effect against DOX-induced cardiotoxicity. The experiments were performed on rat cardiomyocytes (H9c2) and human induced-pluripotent-stem-cell-derived cardiomyocytes (hiPSC-CMs) as a well-established model for cardiac toxicity assessment. CA derivatives protected cardiomyocytes by ameliorating DOX-induced oxidative stress and viability reduction. Our data indicated that they attenuated the chemotherapeutic's toxicity by downregulating levels of caspase-3 and -7. Pre-incubation of cardiomyocytes with CA derivatives prevented DOX-induced motility inhibition in a wound-healing assay and limited cytoskeleton rearrangement. Detailed safety analyses-including hepatotoxicity, mutagenic potential, and interaction with the hERG channel-were performed for the most promising compounds. We concluded that CA derivatives show a multidirectional protective effect against DOX-induced cardiotoxicity. The results should encourage further research to elucidate the exact molecular mechanism of the compounds' activity. The lead structure of the analyzed CA derivatives may serve as a starting point for the development of novel therapeutics to support patients undergoing DOX therapy.
No takes yet. Share an insight, caveat, or question.
Koczurkiewicz et al. (2021) studied Doxorubicin-induced cardiotoxicity. Cinnamic acid (CA) derivatives vs. Doxorubicin alone / control was evaluated on Oxidative stress, viability reduction, caspase-3 and -7 levels, motility inhibition, and cytoskeleton rearrangement. Cinnamic acid derivatives protected rat and human cardiomyocytes against doxorubicin-induced cardiotoxicity by ameliorating oxidative stress, reducing caspase levels, and preventing motility inhibition.
Synapse has enriched 10 related papers. Consider them for comparative context: